SEC 13F Intelligence

D. E. Shaw & Co., Inc. / GILD

D. E. Shaw & Co., Inc.’s Gilead Sciences Inc Position

Does D. E. Shaw & Co., Inc. own Gilead Sciences Inc (GILD)? Yes — 200.9K shares worth $28M (+0.02% of its 13F portfolio) as of Q1 2026, up from 192.7K shares the prior filed quarter.

Position Value
$28M
Q1 2026
Shares
200.9K
% of Portfolio
+0.02%
Quarters Held
28
currently held

Position History GILD

Reported value by quarter
Q4 ’18: $149MQ4 ’18Q1 ’19: $416MQ2 ’19: $418MQ3 ’19: $350MQ4 ’19: $315MQ4 ’19Q1 ’20: $72MQ2 ’20: $33MQ3 ’20: $21MQ4 ’20: $22MQ4 ’20Q1 ’21: $39MQ4 ’21: $50MQ1 ’22: $306MQ2 ’22: $110MQ2 ’22Q3 ’22: $28MQ4 ’22: $173MQ1 ’23: $152MQ2 ’23: $158MQ2 ’23Q3 ’23: $175MQ4 ’23: $77MQ1 ’24: $83MQ2 ’24: $229MQ2 ’24Q3 ’24: $62MQ4 ’24: $94MQ1 ’25: $51MQ2 ’25: $78MQ2 ’25Q3 ’25: $46MQ4 ’25: $24MQ1 ’26: $28Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026200.9K$28M+0.02%
Q4 2025192.7K$24M+0.01%
Q3 2025413.8K$46M+0.03%
Q2 2025700.2K$78M+0.06%
Q1 2025453.8K$51M+0.05%
Q4 20241.01M$94M+0.07%
Q3 2024741.2K$62M+0.05%
Q2 20243.34M$229M+0.21%
Q1 20241.13M$83M+0.07%
Q4 2023956.6K$77M+0.07%
Q3 20232.33M$175M+0.18%
Q2 20232.05M$158M+0.16%
Q1 20231.84M$152M+0.16%
Q4 20222.02M$173M+0.19%
Q3 2022452.0K$28M+0.03%
Q2 20221.77M$110M+0.13%
Q1 20225.15M$306M+0.29%
Q4 2021691.3K$50M+0.04%
Q1 2021609.2K$39M+0.04%
Q4 2020371.0K$22M+0.02%
Q3 2020325.9K$21M+0.02%
Q2 2020430.3K$33M+0.04%
Q1 2020968.4K$72M+0.11%
Q4 20194.85M$315M+0.36%
Q3 20195.52M$350M+0.43%
Q2 20196.18M$418M+0.52%
Q1 20196.40M$416M+0.54%
Q4 20182.39M$149M+0.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See D. E. Shaw & Co., Inc.’s full portfolio or all institutional holders of GILD.